MRVI
Maravai Lifesciences Holdings Inc
NASDAQ: MRVI · HEALTHCARE · BIOTECHNOLOGY
$8.50
+2.91% today
Updated 2026-10-28
Market cap
$2.71B
P/E ratio
—
P/S ratio
12.99x
EPS (TTM)
$-0.53
Dividend yield
—
52W range
$3 – $9
Volume
3.5M
Maravai Lifesciences Holdings Inc (MRVI) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$8.50
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.8B | $0.9B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -8.15% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -37.10%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.